drugset / Trial / NCT06579482

Clinical Trial of Aesculus Hippocastanum and Associations Versus Diosmina and Hesperidina in Chronic Venous Insuficiency

NCT06579482 ↗

Phase 4 Completed 120 enrolled Fundação Educacional Serra dos Órgãos
RandomizedParallel-groupTriple-blindTreatment

Summary

To demonstrate the clinical non-inferiority of efficacy between Aesculus hippocastanum, Polygonum acre, Smilax Pepyracea, Rutin and Diosmin 450mg and Hesperidin 50mg tablets in the improvement of lower limb symptoms assessed by means of a 100mm visual scale (VAS) over 3 months among adult patients presenting with chronic venous insufficiency of the lower limbs.

Timeline

Start
2024-11-06
Primary completion
2025-05-05
Completion
2025-06-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diosmin Small molecule 450 mg —
Subject Hesperidin Small molecule 50 mg —
Subject Horse Chestnut Unknown 50 mg —
Subject Polygonum acre Unknown 10 mg —
Subject Rutin Unknown 20 mg —
Subject Smilax Pepyracea Unknown 40 mg —